SCHEMBL4029179

SCHEMBL4029179

CCCCCc1cc(C(=O)c2ccccc2)no1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARA Q07869 1/20 0.52
▸ SMN1; SMN2 Q16637 6/20 0.50
▸ RAB9A P51151 4/20 0.50
▸ NPC1 O15118 3/20 0.50
▸ ALDH1A1 P00352 2/20 0.50
▸ HPGD P15428 2/20 0.50
▸ MEN1 O00255 2/20 0.50
▸ MAPT P10636 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ POLB P06746 1/20 0.50
▸ PKM P14618 1/20 0.50
▸ MAPK1 P28482 3/20 0.47
▸ HDAC6 Q9UBN7 3/20 0.47
▸ HDAC3 O15379 2/20 0.46
▸ HDAC1 Q13547 2/20 0.46
▸ HDAC2 Q92769 2/20 0.46
▸ HDAC10 Q969S8 1/20 0.46
▸ RIPK1 Q13546 1/20 0.46
▸ ATM Q13315 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4033544 0.99 PPARA (0.54) PPARASMN1; SMN2RAB9ANPC1ALDH1A1
SCHEMBL4024354 0.96 SMN1; SMN2 (0.51) PPARASMN1; SMN2RAB9ANPC1ALDH1A1
SCHEMBL4030511 0.90 SMN1; SMN2 (0.60) SMN1; SMN2RAB9ANPC1ALDH1A1HPGD
SCHEMBL10928518 0.87 RAB9A (0.51) PPARASMN1; SMN2RAB9ANPC1ALDH1A1
SCHEMBL10924712 0.82 RAB9A (0.55) SMN1; SMN2RAB9ANPC1ALDH1A1HPGD
SCHEMBL4016809 0.82 PPARA (0.60) PPARASMN1; SMN2RAB9ANPC1ALDH1A1
SCHEMBL7501852 0.80 PPARA (0.62) PPARASMN1; SMN2RAB9ANPC1ALDH1A1
SCHEMBL11717092 0.80 PPARA (0.62) PPARASMN1; SMN2RAB9ANPC1ALDH1A1
SCHEMBL11722901 0.80 PPARA (0.62) PPARASMN1; SMN2RAB9ANPC1ALDH1A1
SCHEMBL4024862 0.79 PPARA (0.56) PPARASMN1; SMN2RAB9ANPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060247288-A1 Method for manufacturing isoxazole derivative or dihydroisoxazole derivative GAKUIN, RIKKYO (JP) 2006-11-02 — — US claimed
US-7495107-B2 Method for manufacturing isoxazole derivative or dihydroisoxazole derivative RIKKYO GAKUIN (JP) 2009-02-24 — — US disclosed
US-20060247288-A1 Method for manufacturing isoxazole derivative or dihydroisoxazole derivative GAKUIN, RIKKYO (JP) 2006-11-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060247288-A1 Method for manufacturing isoxazole derivative or dihydroisoxazole derivative CYP3A7, NDUFS7, IDH3A PPARA 4148/4885SMN1; SMN2 4090/4885RAB9A 4172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback